Arbutus Biopharma (ABUS) Cash from Investing Activities (2013 - 2026)
Arbutus Biopharma (ABUS) posted Cash from Investing Activities of -$1.66 million for Q2 2026, compared with $15.61 million a year earlier.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Cash from Investing Activities (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Cash from Investing Activities at Arbutus Biopharma was -$10.84 million; for FY2025, it came in at $15.58 million, down 32.1% from FY2024.
- In prior years, Arbutus Biopharma's Cash from Investing Activities was $22.95 million in FY2024 (-54.8%), $50.77 million in FY2023, -$74.94 million in FY2022 and -$12.68 million in FY2021.
- Quarterly Cash from Investing Activities has run from a low of -$60.06 million in Q1 2022 to a high of $22.23 million in Q4 2023 over five years.
- On a year-over-year basis, Cash from Investing Activities increased in 1 of the last four quarters, with an average decline of 16.1%.
- The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q2 2024, with growth of 582.1%; the weakest was Q1 2026, with a decline of 80.6%.
- According to Business Quant data, Cash from Investing Activities for the three prior quarters was $2.2 million (Q1 2026), -$1.36 million (Q4 2025) and -$10.02 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Arbutus Biopharma | 879.47 Mn | 506.45 Mn | - | -1.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.66 Mn |
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Sep 30, 2025 | -10.02 Mn |
| Jun 30, 2025 | 15.61 Mn |
| Mar 31, 2025 | 11.35 Mn |
| Dec 31, 2024 | 13.41 Mn |
| Sep 30, 2024 | -11.99 Mn |
| Jun 30, 2024 | 9.83 Mn |
| Mar 31, 2024 | 11.69 Mn |
| Dec 31, 2023 | 22.23 Mn |
| Sep 30, 2023 | 10.43 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 16.68 Mn |
| Dec 31, 2022 | 12.68 Mn |
| Sep 30, 2022 | -13.74 Mn |
| Jun 30, 2022 | -13.83 Mn |
| Mar 31, 2022 | -60.06 Mn |
| Dec 31, 2021 | -8.12 Mn |
| Sep 30, 2021 | 15.97 Mn |
API Access
Arbutus Biopharma Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();